September 26, 2024 at 10:30 am

TFF Pharmaceuticals’ (TFFP) Thin Film Freezing Technology Demonstrates Superior Pulmonary Drug Delivery

TFF Pharmaceuticals (Nasdaq: TFFP) leads the PRISM Emerging Pharmaceuticals Index with its shares trading up 7% after announcing promising preclinical data published in the “Journal of Drug Delivery Science and Technology.” The company is focused on transforming medicines into stable dry powders, offering alternatives to traditional injection methods. With its proprietary Thin Film Freezing (TFF)… [Read More]
September 25, 2024 at 12:26 pm

Polestar (PSNY) Opens Tech Hub In India Via Partnership with Infosys

PRISM Emerging EV Index company Polestar (PSNY) has entered into a strategic partnership with Infosys (INFY) who is a global leader in next-gen digital services and consulting. This collaboration is focused on supporting Polestar’s advancements in in-car infotainment, Software and Electrical/Electronics (SW&EE) engineering, user experience (UX), and cloud-based digital services. Infosys will further strengthen this… [Read More]
September 24, 2024 at 9:05 pm

Capricor Therapeutics Announces Plans to File BLA for Deramiocel in the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy, Shares Close Up 52%

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on cell and exosome-based therapies, has announced its intent to file a Biologics License Application (BLA) for deramiocel (CAP-1002) for the treatment of cardiomyopathy in Duchenne muscular dystrophy (DMD) patients. The BLA submission is expected to begin in October 2024 and will be supported by positive cardiac… [Read More]
September 24, 2024 at 2:02 pm

Tilray Unveils New Way to Catch a Beverage Buzz with Delta-9 THC Drink Portfolio To Be Launched in US Markets Next Month

The leading global lifestyle and consumer packaged goods company, Tilray Brands (TLRY) has introduced its new hemp-derived Delta-9 THC beverages (HDD9) via its newly formed Tilray Alternative Beverages business. These beverages are expected to launch in October 2024 across Tilray’s US key markets. Prior to this announcement, the company had been investing in its beverage… [Read More]
September 24, 2024 at 9:07 am

Lipella Pharmaceuticals (LIPO) Announces Early Tolerability Results in Phase 2a Trial for Oral Lichen Planus

Today the clinical stage biopharmaceutical company Lipella Pharmaceuticals (LIPO) reported encouraging tolerability results in its Phase 2a trial for its Oral Lichen Planus (OLP) treatment, LP-310.  Three participants have completed the four-week treatment with LP-310, an oral rinse and have reported the treatment was well tolerated with no unpleasant taste. LP-310 is derived from Lipella’s… [Read More]
September 23, 2024 at 3:19 pm

Vistagen Advances Toward New Social Anxiety Treatment with Phase 3 PALISADE-4 Trial of Fasedienol

Vistagen (Nasdaq: VTGN), a biopharmaceutical company focused on treatments for psychiatric and neurological disorders, has begun enrollment in its PALISADE-4 Phase 3 trial. This trial is part of Vistagen’s ongoing efforts to evaluate fasedienol, an investigational nasal spray, for the acute treatment of Social Anxiety Disorder (SAD). SAD affects more than 30 million Americans, and… [Read More]
September 23, 2024 at 2:51 pm

Uranium Energy Corp Leads PRISM MarketView New Energy Index with Acquisition of Rio Tinto's Sweetwater Plant and Wyoming Uranium Assets and Plans to Grow U.S. Production Capacity

Uranium Energy Corp. (NYSE American: UEC) is leading PRISM Market View’s New Energy Index with the news that it has entered into an agreement to acquire Rio Tinto America Inc.’s Wyoming assets. The PRISM Emerging New Energy Index tracks small and micro-cap stocks that contribute to the renewable energy market through other environmentally friendly methods… [Read More]
September 23, 2024 at 2:44 pm

Stocks Steady as Markets Weigh Fed Signals: Market Wrap

US stocks trimmed earlier gains while Treasury yields fell, as investors parsed Federal Reserve comments for insights on future rate cuts following last week’s reduction. The S&P 500 managed a modest 0.2% rise, with Intel and Constellation Energy among the top performers. Intel surged 2.7% after reports of a potential multibillion-dollar investment from Apollo Global… [Read More]
September 23, 2024 at 1:58 pm

ChargePoint Expands EV Charging Network with $19M NEVI Award for California Highways

ChargePoint (NYSE: CHPT) has been awarded over $19 million, through its partners, to install 248 DC fast charging ports at 45 locations along California highways. This funding, part of the National Electric Vehicle Infrastructure (NEVI) program, aims to address EV charging congestion on major routes like I-5. ChargePoint, a leader in EV charging solutions, will… [Read More]